New insights into a spectrum of developmental malformations related to mTOR dysregulations: challenges and...

Area of Science:

• Neuroscience
• Developmental Biology
• Genetics

Background:

• The mammalian target of rapamycin (mTOR) pathway is vital for normal cortical development.
• Aberrant mTOR activation is linked to developmental brain malformations and epilepsy.
• Conditions like focal cortical dysplasia (FCD) and tuberous sclerosis complex (TSC) are known as 'mTORopathies' due to mutations in related genes.

Purpose of the Study:

• To investigate the role of mTOR dysregulation in cortical development and seizure generation.
• To explore the impact of mTOR pathway abnormalities on the surrounding brain environment, including white matter.
• To utilize monogenetic diseases like TSC as models for understanding epileptogenesis and identifying therapeutic targets.

Main Methods:

• Review of existing literature on mTOR pathway involvement in cortical malformations.
• Analysis of genetic and neuropathological data from conditions such as FCD and TSC.
• Comparative study of mTORopathies to understand shared pathogenic mechanisms.

Main Results:

• Constitutive mTOR signaling activation is a common mechanism in developmental malformations with shared features like epilepsy and autism.
• Focal cortical dysplasia type IIb and hemimegalencephaly are identified as the same disease based on developmental neuropathology and genetics.
• Understanding mTOR's effect on the developing cortex and its environment is crucial for comprehending seizure propensity.

Conclusions:

• Dysregulation of the mTOR pathway is a key factor in a spectrum of developmental brain disorders.
• Shared mechanisms link mTORopathies, highlighting potential common therapeutic strategies.
• Further research into mTOR's role is essential for developing novel treatments for epilepsy and related comorbidities.